Human and financial resource needs for universal access to WHO-PEN interventions for diabetes and hypertension care in Eswatini: results from a time-and-motion and bottom-up costing study.

Community outreach Costing Diabetes Differentiated service delivery Eswatini Human resources Hypertension Time-and-motion WHO-PEN

Journal

Human resources for health
ISSN: 1478-4491
Titre abrégé: Hum Resour Health
Pays: England
ID NLM: 101170535

Informations de publication

Date de publication:
27 May 2024
Historique:
received: 13 01 2024
accepted: 16 05 2024
medline: 28 5 2024
pubmed: 28 5 2024
entrez: 27 5 2024
Statut: epublish

Résumé

Eswatini faces persistent challenges in providing care for diabetes and hypertension, exacerbated by a shortage of healthcare workers. The implementation of WHO-PEN interventions aimed to address these issues, yet their effects on healthcare worker time requirements and associated costs remain unclear. This study employed a time-and-motion analysis and a bottom-up cost assessment to quantify the human and financial resources required for scaling up WHO-PEN interventions nationally in Eswatini for all estimated diabetic and hypertensive patients. Findings reveal that healthcare workers in intervention-arm clinics reported longer workday durations compared to those in control-arm clinics, yet spent less time per patient while seeing more patients. The implementation of WHO-PEN interventions increased the workload on healthcare workers but also led to a notable increase in patient care utilization. Furthermore, a morning peak in patient visits was identified, suggesting potential opportunities for optimizing patient flow. Notably, scaling up care provision nationally with WHO-PEN interventions proved to be more cost saving than expanding standard-of-care treatment. WHO-PEN interventions hold promise in improving access to diabetes and hypertension care in Eswatini while offering an efficient solution. However, addressing challenges in healthcare workforce creation and retention is crucial for sustained effectiveness. Policy makers must consider all aspects of the WHO-PEN intervention for informed decision-making. Trial registration US Clinical Trials Registry. NCT04183413. Trial registration date: December 3, 2019. https://ichgcp.net/clinical-trials-registry/NCT04183413.

Sections du résumé

BACKGROUND BACKGROUND
Eswatini faces persistent challenges in providing care for diabetes and hypertension, exacerbated by a shortage of healthcare workers. The implementation of WHO-PEN interventions aimed to address these issues, yet their effects on healthcare worker time requirements and associated costs remain unclear.
METHODS METHODS
This study employed a time-and-motion analysis and a bottom-up cost assessment to quantify the human and financial resources required for scaling up WHO-PEN interventions nationally in Eswatini for all estimated diabetic and hypertensive patients.
RESULTS RESULTS
Findings reveal that healthcare workers in intervention-arm clinics reported longer workday durations compared to those in control-arm clinics, yet spent less time per patient while seeing more patients. The implementation of WHO-PEN interventions increased the workload on healthcare workers but also led to a notable increase in patient care utilization. Furthermore, a morning peak in patient visits was identified, suggesting potential opportunities for optimizing patient flow. Notably, scaling up care provision nationally with WHO-PEN interventions proved to be more cost saving than expanding standard-of-care treatment.
CONCLUSION CONCLUSIONS
WHO-PEN interventions hold promise in improving access to diabetes and hypertension care in Eswatini while offering an efficient solution. However, addressing challenges in healthcare workforce creation and retention is crucial for sustained effectiveness. Policy makers must consider all aspects of the WHO-PEN intervention for informed decision-making. Trial registration US Clinical Trials Registry. NCT04183413. Trial registration date: December 3, 2019. https://ichgcp.net/clinical-trials-registry/NCT04183413.

Identifiants

pubmed: 38802811
doi: 10.1186/s12960-024-00913-0
pii: 10.1186/s12960-024-00913-0
doi:

Banques de données

ClinicalTrials.gov
['NCT04183413']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

32

Subventions

Organisme : HORIZON EUROPE Framework Programme
ID : 825823

Informations de copyright

© 2024. The Author(s).

Références

Ansari-Moghaddam A, Setoodehzadeh F, Khammarnia M, et al. Economic cost of diabetes in the Eastern Mediterranean region countries: a meta-analysis. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):1101–8. https://doi.org/10.1016/j.dsx.2020.06.044 . (ISSN 1871-4021).
doi: 10.1016/j.dsx.2020.06.044
Basu S, Wagner RG, Sewpaul R, Reddy P, Davies J. Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis. Lancet Glob Health. 2019;7(2):e270–80. https://doi.org/10.1016/S2214-109X(18)30450-9 .
doi: 10.1016/S2214-109X(18)30450-9 pubmed: 30528531
Eswatini Ministry of Health. WHO STEPS Non-communicable disease risk factor surveillance report, Swaziland. Geneva: WHO Press; 2014. https://extranet.who.int/ncdsmicrodata/index.php/catalog/688/related-materials . Accessed 13 Dec 2023.
Government of the Kingdom of Eswatini. Budget Estimates 2022–23; 2022. https://www.gov.sz/index.php/budget-monetary-affairs/budget-estimates . Accessed 23 Nov 2023.
Gnugesser E, Chwila C, Brenner S, et al. The economic burden of treating uncomplicated hypertension in Sub-Saharan Africa: a systematic literature review. BMC Public Health. 2022;22:1507. https://doi.org/10.1186/s12889-022-13877-4 .
doi: 10.1186/s12889-022-13877-4 pubmed: 35941626 pmcid: 9358363
Husain MJ, Haider MS, Tarannum R, et al. Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application. BMJ Open. 2022;2022(12): e061467. https://doi.org/10.1136/bmjopen-2022-061467 .
doi: 10.1136/bmjopen-2022-061467
International Monetary Fund. World economic outlook database: October 2023 Edition; 2023. https://www.imf.org/en/Publications/WEO/weo-database/2023/October . Accessed 28 Nov 2023.
Kasper J, Bajunirwe F. Brain drain in sub-Saharan Africa: contributing factors, potential remedies and the role of academic medical centres. Arch Dis Child. 2012;2012(97):973–9.
doi: 10.1136/archdischild-2012-301900
Krishna A, Murali S, Moran AE, et al. Understanding the role of staff nurses in hypertension management in primary care facilities in India: a time-motion study. Prev Chronic Dis. 2023;20:E39. https://doi.org/10.5888/pcd20.220232 . (Published 2023 May 18).
doi: 10.5888/pcd20.220232 pubmed: 37200503 pmcid: 10199685
Kurtz SL. Measuring and accounting for the Hawthorne effect during a direct overt observational study of intensive care unit nurses. Am J Infect Control. 2017;45(9):0196–6553. https://doi.org/10.1016/j.ajic.2017.03.022 .
doi: 10.1016/j.ajic.2017.03.022
Moucheraud C, Lenz C, Latkovic M, Wirtz VJ. The costs of diabetes treatment in low- and middle-income countries: a systematic review. BMJ Glob Health. 2019;4(1): e001258. https://doi.org/10.1136/bmjgh-2018-001258 .
doi: 10.1136/bmjgh-2018-001258 pubmed: 30899566 pmcid: 6407562
Palma AM, Rabkin M, Simelane S, et al. A time-motion study of cardiovascular disease risk factor screening integrated into HIV clinic visits in Swaziland. JIAS. 2018;21(3): e25099. https://doi.org/10.1002/jia2.25099 .
doi: 10.1002/jia2.25099
Peresu E, Heunis JC, Kigozi NG, De Graeve D. Task-shifting directly observed treatment and multidrug-resistant tuberculosis injection administration to lay health workers: stakeholder perceptions in rural Eswatini. Hum Resour Health. 2020;18(1):97. https://doi.org/10.1186/s12960-020-00541-4 .
doi: 10.1186/s12960-020-00541-4 pubmed: 33272307 pmcid: 7712623
Subramanian S, Gakunga R, Kibachio J, et al. Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: patient payments in the private and public sectors. PLoS ONE. 2018;13(1): e0190113. https://doi.org/10.1371/journal.pone.0190113 .
doi: 10.1371/journal.pone.0190113 pubmed: 29304049 pmcid: 5755777
Theilmann M, Ginindza N, Myeni J, et al. Strengthening primary care for diabetes and hypertension in Eswatini: study protocol for a nationwide cluster-randomized controlled trial. Trials. 2023;24:210. https://doi.org/10.1186/s13063-023-07096-4 .
doi: 10.1186/s13063-023-07096-4 pubmed: 36949485 pmcid: 10031170
WHO. The National Health Workforce Accounts database. Geneva: World Health Organization; 2018. https://www.who.int/data/gho/data/themes/topics/health-workforce . Accessed 22 Mar 2024.
WHO country profile. Eswatini diabetes factsheet; 2020. https://www.who.int/publications/m/item/diabetes-swz-country-profile-2016 . Accessed 4 July 2023.
WHO country profile. Eswatini hypertension factsheet; 2020. https://www.who.int/publications/m/item/hypertension-swz-country-profile-eswatini-2020 . Accessed 4 July 2023.

Auteurs

Harsh Vivek Harkare (HV)

Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland. harshvivek.harkare@swisstph.ch.
University of Basel, Basel, Switzerland. harshvivek.harkare@swisstph.ch.

Brianna Osetinsky (B)

Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Ntombifuthi Ginindza (N)

Ministry of Health in Eswatini, Ministry of Justice & Constitutional Affairs Building, Mhlambanyatsi Road, Mbabane, Eswatini.

Bongekile Thobekile Cindzi (BT)

Clinton Health Access Initiative, Mbhilibhi House, Plot 170, Corner Tsekwane/Mbhilibhi Street, Mbabane, Eswatini.

Nomfundo Mncina (N)

Clinton Health Access Initiative, Mbhilibhi House, Plot 170, Corner Tsekwane/Mbhilibhi Street, Mbabane, Eswatini.

Babatunde Akomolafe (B)

Clinton Health Access Initiative, Mbhilibhi House, Plot 170, Corner Tsekwane/Mbhilibhi Street, Mbabane, Eswatini.

Lisa-Rufaro Marowa (LR)

Clinton Health Access Initiative, Mbhilibhi House, Plot 170, Corner Tsekwane/Mbhilibhi Street, Mbabane, Eswatini.

Nyasatu Ntshalintshali (N)

Clinton Health Access Initiative, Mbhilibhi House, Plot 170, Corner Tsekwane/Mbhilibhi Street, Mbabane, Eswatini.

Fabrizio Tediosi (F)

Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH